174 related articles for article (PubMed ID: 23101592)
41. FMR1 allele frequencies in 51,000 newborns: a large-scale population study in China.
Zhang JY; Wu DW; Yang RL; Zhu L; Jiang MY; Wang WJ; Li XK; Jiang XL; Tong F; Shu Q
World J Pediatr; 2021 Dec; 17(6):653-658. PubMed ID: 34738199
[TBL] [Abstract][Full Text] [Related]
42. [Hair root fragile X mental retardation protein assay for the diagnosis of fragile X syndrome].
Luo XF; Zhong JM; Zhang XZ; Zou Y; Chen Y; Wu HP; Yu XY
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Oct; 11(10):817-20. PubMed ID: 19849940
[TBL] [Abstract][Full Text] [Related]
43. Identification of Males with Cryptic Fragile X Alleles by Methylation-Specific Quantitative Melt Analysis.
Aliaga SM; Slater HR; Francis D; Du Sart D; Li X; Amor DJ; Alliende AM; Santa Maria L; Faundes V; Morales P; Trigo C; Salas I; Curotto B; Godler DE
Clin Chem; 2016 Feb; 62(2):343-52. PubMed ID: 26715660
[TBL] [Abstract][Full Text] [Related]
44. Expand Long PCR for fragile X mutation detection.
Hećimović S; Barisić I; Müller A; Petković I; Barić I; Ligutić I; Pavelić K
Clin Genet; 1997 Sep; 52(3):147-54. PubMed ID: 9377803
[TBL] [Abstract][Full Text] [Related]
45. Improved fluorescent PCR-based assay for sizing CGG repeats at the FRAXA locus.
Houdayer C; Lemonnier A; Gerard M; Chauve C; Tredano M; de Villemeur TB; Aymard P; Bonnefont JP; Feldmann D
Clin Chem Lab Med; 1999 Apr; 37(4):397-402. PubMed ID: 10369109
[TBL] [Abstract][Full Text] [Related]
46. A clinical checklist for fragile X syndrome: screening of Thai boys with developmental delay of unknown cause.
Limprasert P; Ruangdaraganon N; Vasiknanonte P; Sura T; Jaruratanasirikul S; Sriwongpanich N; Sriplung H
J Med Assoc Thai; 2000 Oct; 83(10):1260-6. PubMed ID: 11143494
[TBL] [Abstract][Full Text] [Related]
47. Identification of expanded alleles of the FMR1 gene among high-risk population in Indonesia by using blood spot screening.
Winarni TI; Utari A; Mundhofir FE; Tong T; Durbin-Johnson B; Faradz SM; Tassone F
Genet Test Mol Biomarkers; 2012 Mar; 16(3):162-6. PubMed ID: 21988366
[TBL] [Abstract][Full Text] [Related]
48. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
[TBL] [Abstract][Full Text] [Related]
49. Fragile X analysis of 1112 prenatal samples from 1991 to 2010.
Nolin SL; Glicksman A; Ding X; Ersalesi N; Brown WT; Sherman SL; Dobkin C
Prenat Diagn; 2011 Oct; 31(10):925-31. PubMed ID: 21717484
[TBL] [Abstract][Full Text] [Related]
50. High-risk fragile x screening in Guatemala: use of a new blood spot polymerase chain reaction technique.
Yuhas J; Walichiewicz P; Pan R; Zhang W; Casillas EM; Hagerman RJ; Tassone F
Genet Test Mol Biomarkers; 2009 Dec; 13(6):855-9. PubMed ID: 19810826
[TBL] [Abstract][Full Text] [Related]
51. Molecular diagnosis of Fragile X syndrome.
Sofocleous C; Kolialexi A; Mavrou A
Expert Rev Mol Diagn; 2009 Jan; 9(1):23-30. PubMed ID: 19099346
[TBL] [Abstract][Full Text] [Related]
52. Cascade Screening for Fragile X Syndrome/CGG Repeat Expansions in Children Attending Special Education in Sri Lanka.
Chandrasekara CH; Wijesundera WS; Perera HN; Chong SS; Rajan-Babu IS
PLoS One; 2015; 10(12):e0145537. PubMed ID: 26694146
[TBL] [Abstract][Full Text] [Related]
53. A novel methylation PCR that offers standardized determination of FMR1 methylation and CGG repeat length without southern blot analysis.
Grasso M; Boon EM; Filipovic-Sadic S; van Bunderen PA; Gennaro E; Cao R; Latham GJ; Hadd AG; Coviello DA
J Mol Diagn; 2014 Jan; 16(1):23-31. PubMed ID: 24177047
[TBL] [Abstract][Full Text] [Related]
54. Newborn, carrier, and early childhood screening recommendations for fragile X.
Abrams L; Cronister A; Brown WT; Tassone F; Sherman SL; Finucane B; McConkie-Rosell A; Hagerman R; Kaufmann WE; Picker J; Coffey S; Skinner D; Johnson V; Miller R; Berry-Kravis E
Pediatrics; 2012 Dec; 130(6):1126-35. PubMed ID: 23129072
[TBL] [Abstract][Full Text] [Related]
55. MS-MLPA analysis for FMR1 gene: evaluation in a routine diagnostic setting.
Gatta V; Gennaro E; Franchi S; Cecconi M; Antonucci I; Tommasi M; Palka G; Coviello D; Stuppia L; Grasso M
BMC Med Genet; 2013 Aug; 14():79. PubMed ID: 23914933
[TBL] [Abstract][Full Text] [Related]
56. Molecular diagnosis of Fragile X syndrome in subjects with intellectual disability of unknown origin: implications of its prevalence in regional Pakistan.
Kanwal M; Alyas S; Afzal M; Mansoor A; Abbasi R; Tassone F; Malik S; Mazhar K
PLoS One; 2015; 10(4):e0122213. PubMed ID: 25875842
[TBL] [Abstract][Full Text] [Related]
57. Molecular analysis of patients suspected of Fragile X Syndrome.
Amancio AP; de O Melo CA; de M Vieira A; Minasi LB; de M E Silva D; da Silva CC; da Cruz AD
Genet Mol Res; 2015 Nov; 14(4):14660-9. PubMed ID: 26600526
[TBL] [Abstract][Full Text] [Related]
58. The Fragile X premutation: new insights and clinical consequences.
Van Esch H
Eur J Med Genet; 2006; 49(1):1-8. PubMed ID: 16473304
[TBL] [Abstract][Full Text] [Related]
59. Reliable and sensitive detection of fragile X (expanded) alleles in clinical prenatal DNA samples with a fast turnaround time.
Seneca S; Lissens W; Endels K; Caljon B; Bonduelle M; Keymolen K; De Rademaeker M; Ullmann U; Haentjens P; Van Berkel K; Van Dooren S
J Mol Diagn; 2012 Nov; 14(6):560-8. PubMed ID: 22921311
[TBL] [Abstract][Full Text] [Related]
60. Fragile X syndrome in Korea: a case series and a review of the literature.
Yim SY; Jeon BH; Yang JA; Kim HJ
J Korean Med Sci; 2008 Jun; 23(3):470-6. PubMed ID: 18583885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
